The companies announce the first emergency approval of their mRNA vaccine against COVID-19, with rollout to begin next week.
Moderna’s COVID-19 vaccine shows 95% efficacy
US company second to report impressive efficacy for its COVID-19 vaccine candidate.
Trial COVID-19 vaccine shown to be 90% effective
Pfizer and BioNTech announce vaccine candidate against COVID-19 achieved success in first interim analysis from Phase 3 study.
Black holes take 2020 Nobel prize in physics
Three laureates share this year’s Nobel prize in physics for their discoveries about one of the most exotic phenomena in the universe: the black hole.
Nobel Prize in Medicine awarded for the discovery of hepatitis C
This year’s Nobel Prize in Physiology or Medicine recognizes the achievements made in identifying and treating hepatitis C.
Moderna’s COVID-19 vaccine shows immune response in elderly patients
A small trial indicates that Moderna’s experimental SARS-CoV-2 vaccine is effective and safe in older adults, a population group most vulnerable to severe COVID-19.
Microrobots against harmful polymers in water bodies
Czech researchers developed self-propelled microrobots that decompose complex solid pollutants, such as single use and disposable textile fibers.
Scientists discover new penguin colonies from space
Guano stains on sea ice reveal 11 new emperor penguin colonies in Antarctica.
Our itch to share helps spread misinformation
Studies find social media sharing affects news judgment, but a quick exercise reduces the problem.
Timing of immune response to COVID-19 may contribute to disease severity
The interaction between the innate and the adaptive immune responses to COVID-19 may be impacting disease progression, and the answer might be to suppress them.